14.300
+0,00%
2026-10-15
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +0.5% | -1.1% | 2 / 3 | +101.4% | -0.94 pp | -0.85 pp | +10.8% | 0.64 | 11.98 | 728 | +101,4% | 6,1 | +0,5% | 11.98 | 10.65 | +12,5% |
| Pts | 0 | 0 | 8 | 12 | 4 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 14.300 (close price on 2026-10-15)EPS (TTM): 1.194
Financial charts
1.Revenue & growth
VND bn728Q2/26
1.Revenue & growth
VND bn728Q2/26
2.Profit & growth
VND bn6,14Q2/26
3.Profit mix (Penman)
VND bn25,4Q2/26
4.Margins & cost structure
%3.1%Q2/26
5.Returns & cash cycle
% · days44.0%Q2/26
6.Earnings quality & cash
VND bn86,3Q2/26
7.Asset structure
VND bn686Q2/26
8.Funding & debt health
VND bn · times686Q2/26
9.Revenue backlog
VND bn10,6Q2/26
10.Valuation
times · %12,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %351Q2/26
Adjusted EPS growth, latest quarter
0.5%
Average adjusted EPS growth, 3 quarters
-1.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26